Bookbot
Questo è quello che aggiungi al carrello

Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer

An Update

Parametri

  • 290pagine
  • 11 ore di lettura

Maggiori informazioni sul libro

This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.

Acquisto del libro

Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer, Fritz H. Schröder, Gerald H. Mickisch, Karl H. Kurth

Lingua
Pubblicato
1999
Rilegatura
(Copertina rigida),
Condizioni del libro
In buone condizioni
Prezzo
6,09 €

Metodi di pagamento

Ancora nessuna valutazione.

Titolo
Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer
Sottotitolo
An Update
Lingua
Inglese
Pubblicato
1999
Formato
Copertina rigida
Pagine
290
ISBN10
1850700818
ISBN13
9781850700814
Serie
Descrizione
This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.